Managing Coronary Atherosclerotic Disease in Diabetic Nephropathy: From Risk Assessment to Revascularization

Authors

  • Mahmoud Abdelaziz Abdelrashid, Ahmed Shafie Ammar, Abdulrahman Abdullah Abdulrahman Ibrahim, Shimaa Gamal Zien El Abdeen Author

DOI:

https://doi.org/10.48047/13kbym40

Abstract

Background: Diabetic kidney disease (DKD) is associated with a markedly increased risk of coronary artery disease (CAD) and cardiovascular death. The combined effects of chronic hyperglycemia and impaired renal function promote endothelial injury, inflammation, oxidative stress, vascular calcification, and accelerated atherosclerosis. Consequently, patients with DKD frequentlydevelop more complex and widespread coronary disease and experience less favorable cardiovascular outcomes than individuals without renalinvolvement. 

Downloads

Download data is not yet available.

References

Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415-3537.

Marx N, Federici M, Schütt K, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043-4140.

Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. J Am Coll Cardiol. 2022;79:e21-e129.

Downloads

Published

2024-11-20

Issue

Vol. 53 No. 03 (2024): Year 2024, Volume 53, Issue 3

Section

Original

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  1. Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
  2. Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

How to Cite

Managing Coronary Atherosclerotic Disease in Diabetic Nephropathy: From Risk Assessment to Revascularization (Mahmoud Abdelaziz Abdelrashid, Ahmed Shafie Ammar, Abdulrahman Abdullah Abdulrahman Ibrahim, Shimaa Gamal Zien El Abdeen , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 7872-7878. https://doi.org/10.48047/13kbym40